Basal cell carcinoma is the most common skin cancer diagnosed in the United States. It refers to a cancer derived from cells at the lowest layer of the epidermis, called “basal cells.” Fortunately, it is extremely treatable when caught early and has recurrence rates as low as 2%. Studies have shown a link between the development of this cancer and prolonged exposure to ultraviolet light.
Basal cell carcinoma can present in many different ways. It may appear as a small non-healing sore; a white, pearly bump; a pink scaly patch; or a thin waxy scar. While basal cell carcinoma is most commonly identified on the sun-exposed surfaces of the body, it can occur in sun-protected areas as well. A full body skin cancer screening can help identify any lesions worrisome for basal cell carcinoma, which may require a skin biopsy for confirmation.
Treatment of basal cell carcinoma can vary, but include MOHS micrographic surgery (performed by Dr. Thomas and Dr. Lieberman) or standard excision, curettage, topical chemotherapy, or radiation therapy utilizing the innovative office-based electronic brachytherapy (managed by Dr. Pomerantz and her team). The providers and staff of Thomas Dermatology are experts at tailoring treatment based on specific characteristics of the skin cancer and individual needs of the patient.